2RIP

Structure of DPPIV in complex with an inhibitor

Summary for 2RIP

• Entry DOI: 10.2210/pdb2rip/pdb
• Descriptor: Dipeptidyl peptidase 4, alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (6 entities in total)
• Functional Keywords: dppiv, diabetes, drug design, aminopeptidase, glycoprotein, hydrolase, membrane, protease, secreted, serine protease, signal-anchor, transmembrane
• Biological source: Homo sapiens (human)
• Total number of polymer chains: 1
• Total formula weight: 86975.01

Authors

Qiu, X. (deposition date: 2007-10-12, release date: 2008-03-18, Last modification date: 2024-11-20)

Primary citation

Corbett, J.W.,Dirico, K.,Song, W.,Boscoe, B.P.,Doran, S.D.,Boyer, D.,Qiu, X.,Ammirati, M.,Vanvolkenburg, M.A.,McPherson, R.K.,Parker, J.C.,Cox, E.D.
Design and synthesis of potent amido- and benzyl-substituted cis-3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl DPP-IV inhibitors.
Bioorg.Med.Chem.Lett., 17:6707-6713, 2007

PubMed Abstract: The cis-3-amino-4-(2-cyanopyrrolidide)-pyrrolidine template has been shown to afford low nanomolar inhibitors of human DPP-IV that exhibit a robust PK/PD profile. An X-ray co-crystal structure of 5 confirmed the proposed mode of binding. The potent single digit DPP-IV inhibitor 53 exhibited a preferred PK/PD profile in preclinical animal models and was selected for additional profiling.

PubMed: 17977724
DOI: 10.1016/j.bmcl.2007.10.063

Experimental method

X-RAY DIFFRACTION (2.9 Å)